AF
MDGL icon

Allworth Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Allworth Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86M Buy
3,562
+4
+0.1% +$1.91K 0.01% 548
2025
Q4 		$2.07M Buy
3,558
+10
+0.3% +$5.11K 0.01% 508
2025
Q3 		$1.63M Buy
3,548
+14
+0.4% +$5.22K 0.01% 551
2025
Q2 		$1.07M Buy
3,534
+3,514
+17,570% +$1.05M 0.01% 623
2025
Q1 		$6.4K Buy
20
+3
+18% +$986 ﹤0.01% 2627
2024
Q4 		$5.52K Buy
17
+6
+55% +$1.69K ﹤0.01% 2717
2024
Q3 		$2.33K Hold
11
– – ﹤0.01% 2902
2024
Q2 		$3.16K Sell
11
-1
-8% -$238 ﹤0.01% 2715
2024
Q1 		$3.21K Hold
12
– – ﹤0.01% 2603
2023
Q4 		$2.78K Buy
12
+3
+33% +$525 ﹤0.01% 2529
2023
Q3 		$1.31K Buy
+9
New +$1.69K ﹤0.01% 2733

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allworth Financial's MDGL Position: Q1 2026 in Review

Allworth Financial increased its Madrigal Pharmaceuticals (MDGL) stake by 0.11% in Q1 2026, buying an estimated $1.91K and bringing the position to 3,562 shares worth $1.86M. The position accounts for 0.01% of the portfolio, ranked #548.

Allworth Financial first reported a position in MDGL in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.07M in Q4 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Allworth Financial held 3,562 shares of Madrigal Pharmaceuticals worth $1.86M as of Q1 2026.
  • Allworth Financial bought 4 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $1.91K.
  • Madrigal Pharmaceuticals made up 0.01% of Allworth Financial's portfolio in Q1 2026, its #548 holding.
  • Allworth Financial first reported a position in Madrigal Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • Allworth Financial's Madrigal Pharmaceuticals position peaked at $2.07M in Q4 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.